Company news

Mesoblast Limited news in 2022

Mesoblast Limited's news releases, calls and decks from 2022, newest first.

View company

Extension of Undrawn US$30 million Facility

December 22, 2022

Long-Term Survival for Acute GvHD Treatment with Remestemcel

November 22, 2022

MSB Q1 Financial Results and Operational Highlights

November 22, 2022

First Quarter Financial Results on Form 6-K

November 22, 2022

Submits New Information to FDA IND File for SR-aGVHD

October 2, 2022

MSB Annual Financial Results and Operational Highlights

August 30, 2022

Preliminary Final Report

August 30, 2022

US$45 Million Private Placement to Major Shareholders

August 9, 2022

Reinstatement to Quotation

August 9, 2022

Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE

July 19, 2022

Third Quarter Results Presentation

May 31, 2022

MSB Q3 Financial Results and Operational Highlights

May 31, 2022

S&P DJI Announces March 2022 Quarterly Rebalance

March 4, 2022

Second Quarter Results Presentation

February 24, 2022

Ulcerative Colitis & Crohns Results Presented at ECCO

February 20, 2022

Appendix 4C Quarterly Activity Report

January 30, 2022

Calls in 2022

Decks in 2022